Overexpression of the HER-2/neu receptor is detected in 25–35% of human breast cancer [4,7] but conflicting data exist about the prevalence of HER-2/neu overexpression in colorectal cancer ranging from 0 to 83 %. The gene discussed is ERBB2; the disease is breast carcinoma.